Investlytic Investlytic
Log in Free Account
English
🕒 Last update: loading…

Stock Abivax S.A. ABVX.PA

Abivax S.A. — Investlytic score 2/5 on the five criteria.

-
-
0/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 2/5 criteria met.

  • ✅ Price trend passed
  • ❌ Growth failed
  • ✅ Debt passed
  • ❌ P/E failed
  • ❌ Correction failed

Price trend

Overall trend (8 years): the price has been multiplied by at least 1.5.

Price change 2018 → 2019: 90.46%

Price change 2019 → 2020: 52.55%

Price change 2020 → 2021: -17.01%

Price change 2021 → 2022: -78.35%

Price change 2022 → 2023: 58.90%

Price change 2023 → 2024: -31.16%

Price change 2024 → 2025: 1681.07%

Price change 2025 → 2026: -18.23%

Price change 2026 (year to date): -14.39%

Financial growth

Revenue CAGR (8 years): -100.00%

Earnings CAGR (8 years): N/A

Growth status: insufficient data or negative trend.

Debt

Debt-to-equity ratio: 0.07

Debt/equity < 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: -15.84

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 27.07% from the high over 6 months.

Excessive correction (> 20.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

Create a free account Log in
02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Abivax S.A.–0.07–🔒
bioMérieux S.A.22.50.11+7.6 %–
Emeis–6.11+11.4 %–
Clariane SE565.52.16+12.4 %–
EssilorLuxottica S.A.33.60.37+14.2 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

Create a free account Log in
04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

Create a free account Log in
05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

Create a free account Log in
06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

Create a free account Log in
07

Similar stocks